Serum Elastase Activity, Serum Elastase Inhibitors, and Occurrence of Carotid Atherosclerotic Plaques
- 4 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (22) , 2638-2645
- https://doi.org/10.1161/01.cir.0000017329.51160.ef
Abstract
Background — In the last decades, interest has increased in the potential deleterious atherogenic effects of some cellular elastase activities. The results of experimental and clinical investigations were inconsistent. In this report, we assessed the associations of serum elastase activity and serum elastase inhibitors with carotid plaque occurrence during the 4-year follow-up in a population of 859 subjects free of coronary heart disease and stroke (age, 59 to 71 years). Methods and Results — Serum elastase activity and serum elastase inhibitors were measured at baseline examination. Carotid B-mode ultrasound examination was performed at baseline and 2 years and 4 years later. The occurrence of carotid plaques in subjects with the lowest serum elastase activity values (quartile 1), in those with the intermediate values (quartiles 2 to 3), and in those with the highest values (quartile 4) was, respectively, 24.6%, 18.9%, and 12.2% ( P P P P for trendP P Conclusions — Low values of serum elastase activity and high values of serum elastase inhibitors were strongly and independently associated with increased 4-year carotid plaque occurrence. Further studies are necessary to elucidate the nature of the associations between elastase parameters and atherosclerosis.Keywords
This publication has 16 references indexed in Scilit:
- Elastin–elastase–atherosclerosis revisitedAtherosclerosis, 1998
- Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA studyAtherosclerosis, 1997
- Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.Journal of Clinical Investigation, 1996
- Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The EVA studyAtherosclerosis, 1996
- The Family of Matrix MetalloproteinasesaAnnals of the New York Academy of Sciences, 1994
- Cell‐Matrix Interactions in the Genesis of Arteriosclerosis and AtheromaAnnals of the New York Academy of Sciences, 1992
- Elastase-type enzymes and their relation to blood lipids in atherosclerotic patientsAtherosclerosis, 1992
- Renal sites of action of physiological increases in plasma atrial natriuretic factor concentration in essential hypertensionJournal Of Hypertension, 1992
- The role of α1-antitrypsin deficiency in the pathogenesis of immune disordersClinical Immunology and Immunopathology, 1985
- ANTI-ATHEROSCLEROTIC ACTION OF ELASTASE—WITH SPECIAL REFERENCE TO ITS EFFECT ON ELASTIC FIBRESAge and Ageing, 1983